Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Moodys
Chubb
US Department of Justice
Argus Health
UBS
Fish and Richardson
Mallinckrodt
Colorcon

Generated: August 23, 2017

DrugPatentWatch Database Preview

LIPO-HEPIN Drug Profile

« Back to Dashboard

What is the patent landscape for Lipo-hepin, and what generic Lipo-hepin alternatives are available?

Lipo-hepin is a drug marketed by 3M and is included in one NDA.

The generic ingredient in LIPO-HEPIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for Tradename: LIPO-HEPIN

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list26
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LIPO-HEPIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m
LIPO-HEPIN
heparin sodium
INJECTABLE;INJECTION017027-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
3m
LIPO-HEPIN
heparin sodium
INJECTABLE;INJECTION017027-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
3m
LIPO-HEPIN
heparin sodium
INJECTABLE;INJECTION017027-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
3m
LIPO-HEPIN
heparin sodium
INJECTABLE;INJECTION017027-011Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
3m
LIPO-HEPIN
heparin sodium
INJECTABLE;INJECTION017027-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
US Army
Teva
Express Scripts
Merck
Moodys
Citi
Julphar
Novartis
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot